Logo image of CSGP

COSTAR GROUP INC (CSGP) Stock Fundamental Analysis

NASDAQ:CSGP - Nasdaq - US22160N1090 - Common Stock - Currency: USD

79.7  +0.68 (+0.86%)

After market: 79.7 0 (0%)

Fundamental Rating

5

CSGP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. Both the profitability and the financial health of CSGP get a neutral evaluation. Nothing too spectacular is happening here. CSGP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CSGP was profitable.
CSGP had a positive operating cash flow in the past year.
In the past 5 years CSGP has always been profitable.
In the past 5 years CSGP always reported a positive cash flow from operatings.
CSGP Yearly Net Income VS EBIT VS OCF VS FCFCSGP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

CSGP's Return On Assets of 1.50% is fine compared to the rest of the industry. CSGP outperforms 75.38% of its industry peers.
The Return On Equity of CSGP (1.84%) is better than 73.85% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.04%, CSGP is in line with its industry, outperforming 60.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CSGP is below the industry average of 5.55%.
Industry RankSector Rank
ROA 1.5%
ROE 1.84%
ROIC 0.04%
ROA(3y)3.37%
ROA(5y)3.48%
ROE(3y)4.11%
ROE(5y)4.33%
ROIC(3y)2.11%
ROIC(5y)2.77%
CSGP Yearly ROA, ROE, ROICCSGP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

The Profit Margin of CSGP (5.07%) is better than 80.00% of its industry peers.
In the last couple of years the Profit Margin of CSGP has declined.
With a Operating Margin value of 0.18%, CSGP perfoms like the industry average, outperforming 58.46% of the companies in the same industry.
CSGP's Operating Margin has declined in the last couple of years.
CSGP has a better Gross Margin (79.59%) than 92.31% of its industry peers.
In the last couple of years the Gross Margin of CSGP has remained more or less at the same level.
Industry RankSector Rank
OM 0.18%
PM (TTM) 5.07%
GM 79.59%
OM growth 3Y-80.23%
OM growth 5Y-63.35%
PM growth 3Y-30.42%
PM growth 5Y-25.78%
GM growth 3Y-0.84%
GM growth 5Y0.06%
CSGP Yearly Profit, Operating, Gross MarginsCSGP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CSGP is destroying value.
The number of shares outstanding for CSGP has been increased compared to 1 year ago.
Compared to 5 years ago, CSGP has more shares outstanding
The debt/assets ratio for CSGP has been reduced compared to a year ago.
CSGP Yearly Shares OutstandingCSGP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CSGP Yearly Total Debt VS Total AssetsCSGP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 13.06 indicates that CSGP is not in any danger for bankruptcy at the moment.
The Altman-Z score of CSGP (13.06) is better than 90.77% of its industry peers.
CSGP has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CSGP (0.13) is better than 73.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 13.06
ROIC/WACC0
WACC8.78%
CSGP Yearly LT Debt VS Equity VS FCFCSGP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

CSGP has a Current Ratio of 8.96. This indicates that CSGP is financially healthy and has no problem in meeting its short term obligations.
CSGP's Current ratio of 8.96 is amongst the best of the industry. CSGP outperforms 89.23% of its industry peers.
CSGP has a Quick Ratio of 8.96. This indicates that CSGP is financially healthy and has no problem in meeting its short term obligations.
CSGP has a better Quick ratio (8.96) than 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 8.96
Quick Ratio 8.96
CSGP Yearly Current Assets VS Current LiabilitesCSGP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

6

3. Growth

3.1 Past

The earnings per share for CSGP have decreased strongly by -41.46% in the last year.
The Earnings Per Share has been decreasing by -6.71% on average over the past years.
The Revenue has grown by 11.45% in the past year. This is quite good.
CSGP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.35% yearly.
EPS 1Y (TTM)-41.46%
EPS 3Y-14.08%
EPS 5Y-6.71%
EPS Q2Q%-24.24%
Revenue 1Y (TTM)11.45%
Revenue growth 3Y12.07%
Revenue growth 5Y14.35%
Sales Q2Q%10.83%

3.2 Future

CSGP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.19% yearly.
CSGP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.54% yearly.
EPS Next Y20.7%
EPS Next 2Y39.62%
EPS Next 3Y37.87%
EPS Next 5Y37.19%
Revenue Next Year13.85%
Revenue Next 2Y12.96%
Revenue Next 3Y13.08%
Revenue Next 5Y12.54%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CSGP Yearly Revenue VS EstimatesCSGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
CSGP Yearly EPS VS EstimatesCSGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 110.69, the valuation of CSGP can be described as expensive.
CSGP's Price/Earnings ratio is in line with the industry average.
CSGP's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.29.
The Price/Forward Earnings ratio is 91.71, which means the current valuation is very expensive for CSGP.
Based on the Price/Forward Earnings ratio, CSGP is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
CSGP's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.32.
Industry RankSector Rank
PE 110.69
Fwd PE 91.71
CSGP Price Earnings VS Forward Price EarningsCSGP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CSGP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 197.36
CSGP Per share dataCSGP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CSGP's earnings are expected to grow with 37.87% in the coming years.
PEG (NY)5.35
PEG (5Y)N/A
EPS Next 2Y39.62%
EPS Next 3Y37.87%

0

5. Dividend

5.1 Amount

No dividends for CSGP!.
Industry RankSector Rank
Dividend Yield N/A

COSTAR GROUP INC

NASDAQ:CSGP (4/17/2025, 8:11:03 PM)

After market: 79.7 0 (0%)

79.7

+0.68 (+0.86%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners103.39%
Inst Owner Change0.15%
Ins Owners1.06%
Ins Owner Change11.97%
Market Cap33.61B
Analysts80
Price Target87.07 (9.25%)
Short Float %3.79%
Short Ratio4.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.34%
Min EPS beat(2)13.92%
Max EPS beat(2)32.76%
EPS beat(4)4
Avg EPS beat(4)38.93%
Min EPS beat(4)13.92%
Max EPS beat(4)59.97%
EPS beat(8)7
Avg EPS beat(8)21.33%
EPS beat(12)11
Avg EPS beat(12)20.12%
EPS beat(16)15
Avg EPS beat(16)18.08%
Revenue beat(2)0
Avg Revenue beat(2)-1.76%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)-1.07%
Revenue beat(4)0
Avg Revenue beat(4)-1.6%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)-1.01%
Revenue beat(8)0
Avg Revenue beat(8)-1.61%
Revenue beat(12)0
Avg Revenue beat(12)-1.63%
Revenue beat(16)1
Avg Revenue beat(16)-1.44%
PT rev (1m)-0.33%
PT rev (3m)-6.28%
EPS NQ rev (1m)-21.95%
EPS NQ rev (3m)-53.94%
EPS NY rev (1m)-19.67%
EPS NY rev (3m)-24.73%
Revenue NQ rev (1m)1.04%
Revenue NQ rev (3m)-0.98%
Revenue NY rev (1m)2.99%
Revenue NY rev (3m)0.92%
Valuation
Industry RankSector Rank
PE 110.69
Fwd PE 91.71
P/S 12.29
P/FCF N/A
P/OCF 85.62
P/B 4.45
P/tB 7.32
EV/EBITDA 197.36
EPS(TTM)0.72
EY0.9%
EPS(NY)0.87
Fwd EY1.09%
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)0.93
OCFY1.17%
SpS6.49
BVpS17.91
TBVpS10.89
PEG (NY)5.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.5%
ROE 1.84%
ROCE 0.06%
ROIC 0.04%
ROICexc 0.08%
ROICexgc 0.32%
OM 0.18%
PM (TTM) 5.07%
GM 79.59%
FCFM N/A
ROA(3y)3.37%
ROA(5y)3.48%
ROE(3y)4.11%
ROE(5y)4.33%
ROIC(3y)2.11%
ROIC(5y)2.77%
ROICexc(3y)5.52%
ROICexc(5y)6.72%
ROICexgc(3y)37.51%
ROICexgc(5y)65.24%
ROCE(3y)3%
ROCE(5y)3.93%
ROICexcg growth 3Y-84.93%
ROICexcg growth 5Y-68.06%
ROICexc growth 3Y-79.71%
ROICexc growth 5Y-61.67%
OM growth 3Y-80.23%
OM growth 5Y-63.35%
PM growth 3Y-30.42%
PM growth 5Y-25.78%
GM growth 3Y-0.84%
GM growth 5Y0.06%
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA 6.6
Cap/Depr 434.24%
Cap/Sales 23.31%
Interest Coverage 0.15
Cash Conversion 258.8%
Profit Quality N/A
Current Ratio 8.96
Quick Ratio 8.96
Altman-Z 13.06
F-Score5
WACC8.78%
ROIC/WACC0
Cap/Depr(3y)211.68%
Cap/Depr(5y)162.35%
Cap/Sales(3y)11.14%
Cap/Sales(5y)9.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.46%
EPS 3Y-14.08%
EPS 5Y-6.71%
EPS Q2Q%-24.24%
EPS Next Y20.7%
EPS Next 2Y39.62%
EPS Next 3Y37.87%
EPS Next 5Y37.19%
Revenue 1Y (TTM)11.45%
Revenue growth 3Y12.07%
Revenue growth 5Y14.35%
Sales Q2Q%10.83%
Revenue Next Year13.85%
Revenue Next 2Y12.96%
Revenue Next 3Y13.08%
Revenue Next 5Y12.54%
EBIT growth 1Y-98.3%
EBIT growth 3Y-77.85%
EBIT growth 5Y-58.09%
EBIT Next Year3050.53%
EBIT Next 3Y326.57%
EBIT Next 5Y148.85%
FCF growth 1Y-170.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.8%
OCF growth 3Y-5.8%
OCF growth 5Y-3.03%